Hezhao Zhao
Overview
Explore the profile of Hezhao Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duan W, Hosea R, Wang L, Ruan C, Zhao F, Liu J, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2409769.
PMID: 39903759
Immune checkpoint inhibitor (ICI) therapy is a promising anti-tumor therapeutic strategy; however, its efficacy in solid tumors is limited. Chromosome missegregation is common in various solid tumors; however, its role...
2.
Li W, Huang C, Qiu L, Tang Y, Zhang X, Zhang L, et al.
Oncogene
. 2024 May;
43(27):2115-2131.
PMID: 38773262
Cancer stem cells (CSCs), which are distinct subpopulations of tumor cells, have a substantially higher tumor-initiating capacity and are closely related to poor clinical outcomes. Damage to organelles can trigger...
3.
Hosea R, Duan W, Meliala I, Li W, Wei M, Hillary S, et al.
Adv Sci (Weinh)
. 2024 Apr;
11(26):e2308690.
PMID: 38682484
Spindle assembly checkpoint (SAC) is a crucial safeguard mechanism of mitosis fidelity that ensures equal division of duplicated chromosomes to the two progeny cells. Impaired SAC can lead to chromosomal...
4.
Luo X, Wei M, Li W, Zhao H, Kasim V, Wu S
Int J Biol Sci
. 2023 Oct;
19(14):4525-4538.
PMID: 37781025
Metabolic reprogramming is a hallmark of cancers crucial for fulfilling the needs of energy, building blocks, and antioxidants to support tumor cells' rapid proliferation and to cope with the harsh...
5.
Li J, Luo X, Wei M, Li Z, Li Y, Zhao H, et al.
Biomed Pharmacother
. 2023 Jun;
165:115006.
PMID: 37327589
Metabolic reprogramming is one of the key features of tumors facilitating their rapid proliferation and adaptation to harsh microenvironments. Yin Yang 2 (YY2) has recently been reported as a tumor...
6.
Tang Y, Li W, Qiu L, Zhang X, Zhang L, Miyagishi M, et al.
Oncogenesis
. 2023 Mar;
12(1):17.
PMID: 36977688
Abnormal glucose metabolism is a highlight of tumor metabolic reprogramming and is closely related to the development of malignancies. p52-ZER6, a CH-type zinc finger protein, promotes cell proliferation and tumorigenesis....
7.
Liu J, Lu R, Zheng X, Hou W, Wu X, Zhao H, et al.
Biomater Sci
. 2023 Feb;
11(7):2504-2517.
PMID: 36779280
Supplemental has been shown to aid in the prevention, alleviation, and treatment of inflammatory bowel disease (IBD), but the progression and mechanisms are largely unstudied, partly because of a lack...
8.
Li Y, Li J, Li Z, Wei M, Zhao H, Miyagishi M, et al.
Adv Sci (Weinh)
. 2022 Mar;
9(13):e2104836.
PMID: 35246964
Ferroptosis is a type of programmed cell death caused by disruption of redox homeostasis and is closely linked to amino acid metabolism. Yin Yang 2 (YY2) and its homolog Yin...
9.
Li Z, He Y, Li Y, Li J, Zhao H, Song G, et al.
Oncogene
. 2021 Oct;
40(50):6736-6747.
PMID: 34657129
Tumor metabolic reprogramming ensures that cancerous cells obtain sufficient building blocks, energy, and antioxidants to sustain rapid growth and for coping with oxidative stress. Neurogenic differentiation factor 1 (NeuroD1) is...
10.
Yu P, Wei K, Zhang T, Tan Z, Zhao H, Sun H
Cancer Manag Res
. 2021 Aug;
13:6079-6088.
PMID: 34377026
Background: Growing evidence indicated that circRNAs played major roles in the progression of human cancer. Nevertheless, the molecular mechanism and effects of circTMCO3 in GC are still unclear. Methods: First,...